Cisplatin and capecitabine
WebJan 19, 2024 · In the second-line setting, the ABC-06 trial of 162 patients with advanced biliary tract cancer demonstrated a significant, albeit modest, survival benefit for oxaliplatin-based combination therapy versus active symptom control alone after failure of an initial cisplatin/gemcitabine regimen (median 6.2 versus 5.3 months) [ 2 ]. WebMay 1, 2024 · Objective: To determine whether induction chemotherapy with paclitaxel, cisplatin, and capecitabine (TPC) improves survival vs cisplatin and fluorouracil …
Cisplatin and capecitabine
Did you know?
WebIt is usual to have a cycle of cisplatin and capecitabine every three weeks for up to six cycles. This can vary, your doctor will discuss the exact number of cycles you will have. … WebOct 6, 2014 · To compare epirubicin, cisplatin, and capecitabine (ECX) with fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatments in patients with advanced gastric or esophagogastric junction (EGJ) adenocarcinoma. Patients and Methods This open, randomized, phase III study was carried out in 71 centers.
WebNov 13, 2024 · For instance, cisplatin, paclitaxel, oxaliplatin, or docetaxel might cause nerve damage (called peripheral neuropathy ). This can lead to numbness, tingling, sensitivity to cold, or pain in the hands and feet. Most side effects get better over time once treatment stops, but some can last a long time or even be permanent. WebMar 15, 2024 · Trastuzumab plus fluorouracil and cisplatin; FOLFOX plus trastuzumab; Capecitabine and oxaliplatin (CAPOX) plus trastuzumab; Concurrent …
WebConclusions: Camrelizumab and apatinib combined with induction chemotherapy of NAB-paclitaxel, cisplatin and capecitabine and CCRT shows excellent distant metastatic control with acceptable safety, which is a new promising and effective systemic therapy regimen for high-risk of metastatic NPC patients. Clinical trial information: ChiCTR2000032317. WebJun 23, 2014 · This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients after curative intent resection of BTC. Detailed Description:
WebSep 25, 2024 · Patients were randomly assigned (1:1) to receive rilotumumab plus epirubicin, cisplatin, and capecitabine or placebo plus epirubicin, cisplatin, and capecitabine. The randomisation list was generated by fixed stratified permuted block randomisation, with a block size of four, and prepared by an individual who was …
WebConclusions: Epirubicin, cisplatin, and capecitabine seems to be active in platinum-resistant relapsed EOC with manageable toxicity. Further prospective investigation of platinum-anthracycline combinations is warranted in patients who relapse 3 to 6 months after first-line platinum-taxane treatment. Publication types Clinical Trial MeSH terms citroen c1 airbag light flashingWebCisplatin is a platinum-based agent whose nephrotoxicity is thought related to the chloride in the cis position. Cisplatin gains entry into tubular cells via uptake by the OCT-2 … dick mods for fallout 4WebJun 1, 2010 · Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by poor prognosis. First-line systemic treatments in advanced disease include mitotane, either alone or in combination with chemotherapy. Studies evaluating second-line therapy options have obtained disappointing results. This trial assessed the activity and toxicity of gemcitabine … dick mod for minecraftWebMar 1, 2013 · The patients were given docetaxel at 60 mg/m² on day 1, cisplatin at 20 mg/m² on days 1-3, and capecitabine at 1 250 mg/m² on days 1-14, and the treatment cycle was repeated ever 3 weeks. citroen c1 attractionWebThis study looks at outcomes for cisplatin plus capecitabine (PX) outside of a trial setting. Methods: Cisplatin (mean dose 75 mg/m²) was given on day 1 of a 3-week cycle and … citroën c1 attraction 2009WebApr 12, 2024 · Currently, gemcitabine/cisplatin is first-line therapy for advanced iCCA based on the ABC-02 clinical trial (ClinicalTrials.gov identifier NCT02170090). That … dick monfort net worthWebOct 31, 2024 · Options include infusional 5-fluorouracil (5-FU), capecitabine, S-1 and other oral 5-FU pro-drugs and cisplatin or oxaliplatin. The addition of docetaxel to 5-FU/cisplatin is an option for young and fit patients, based on a phase III study, but is associated with significant hematologic toxicity and modest benefit. dick moerman scottish liberal democrats